Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4 by unknown
Interleukin  12  Signaling  in T  Helper Type  1 (Thl) 
Cells Involves Tyrosine  Phosphorylation  of Signal 
Transducer and Activator  of Transcription  (Stat)3 
and Stat4 
By Nils G. Jacobson,* Susanne J. Szabo,* Renate M. Weber-Nor&,* 
Zhong Zhong,~ Robert D. Schreiber,* James E. Darnell, Jr.,~ 
and Kenneth M. Murphy* 
From the  *Department of Pathology, Washington University School of Medicine, St.  Louis, 
Missouri 63110; and *Laboratory of Molecular Cell Biology, The Rockefeller University, 
New York 10021 
Slllnmary 
Interleukin 12 (IL-12) initiates  the differentiation of naive CD4 + T ceils to T helper type 1 (Thl) 
cells critical for resistance to intracellular  pathogens  such as Leishmania  major.  To explore the 
basis of IL-12 action,  we analyzed induction  of nuclear factors in Thl  cells.  IL-12 selectively 
induced nuclear DNA-binding complexes that contained Star3 and Stat4,  recently cloned members 
of the family of signal transducers and activators of transcription (STATs). While Stat3 participates 
in signaling  for several other cytokines, Stat4 was not previously known to participate in the 
signaling pathway for any natural ligand.  The selective activation of Stat4 provides a basis for 
unique actions of IL-12 on Thl development. Thus,  this study presents the first identification 
of the early events in IL-12 signaling  in T  cells  and of ligand  activation  of Stat4. 
C 
Ytokines regulate the development of Thl and Th2 sub- 
sets during  primary T  cell activation  (1-15).  We and 
others recently showed that  IL-12 induces development of 
Thl ceils, which secrete IL-2, IFN-3', and lymphotoxin and 
promote cell-mediated immune responses (1,  2,  16-18).  In 
contrast,  IL-4 induces development of Th2 cells, which se- 
crete IL-4, -5, -6, and -10 (1, 2, 19, 20). IL-12 is a covalent 
heterodimer of p35 and p40 subunits (21-23) that binds to 
cell surface receptors on lymphocytes (24). Besides inducing 
Thl differentiation (1, 2), IL-12 can augment Thl cytokine 
(e.g., IFN-3') production and cellular proliferation during an- 
tigenic stimulation (25-27). While IL-12 and IL-4 are crit- 
ical  in directing  the development  of naive T  cells,  little is 
known  about  the  intracellular  signals  delivered  by  these 
cytokines to promote differentiation. 
Several cytokines, including IFN-c~, IFN-'y, IL-6, prolactin, 
epidermal growth factor, and platelet-derived growth factor 
(PDGF), 1 deliver signals  through  the Jak-STAT  family of 
signal transduction molecules (4-9,  28, 29). Receptor acti- 
vation leads to rapid recruitment and tyrosine phosphoryla- 
tion of specific members of the STAT family, inducing their 
dimerization,  nuclear translocation,  and binding to specific 
1 Abbreviations used in this paper: EMSA, electrophoretic mobility shift 
assay; PDGF, platelet-derived growth factor; STAT, signal transducer and 
activator of transcription. 
DNA sequences in target genes (4, 30-32). Besides forming 
homodimers, STAT members can also form heterodimers, such 
as the epidermal  growth factor-induced SIF-B complex,  a 
heterodimer  of Statl  and Stat3  (9).  While  several of these 
cytokines activate Statl, 2, 3, 5, and 6, none have been shown 
to activate Stat4  (5,  6). 
In this report we examined the signaling pathway used by 
IL-12 in Thl  cells. We report that  IL-12 induces the rapid 
tyrosine phosphorylation of Stat3 and Stat4 and formation 
of nuclear complexes capable of binding to DNA sequences 
related to IFN-'y activation site (GAS) elements. This report 
provides the first identification of a ligand to activate Stat4 
and of a transcription complex induced by IL-12. These results 
open the way to examination of the molecular basis ofT helper 
cell development and commitment. 
Materials and Methods 
Reagents and Cytokines.  Genistein, PMA, and ionomycin were 
purchased from Sigma Chemical Co. (St. Louis, MO); poly-dIdC 
was from Pharmacia LKB Biotechnology, Inc. (Piscataway, NJ); 
and media were from Washington University Tissue Culture Sup- 
port Center (St. Louis, MO). Human rib2 was supplied by Takeda 
(Osaka, Japan); murine IL-4 was produced as high titer culture su- 
pernatant of transfected P815 mastocytoma cells; murine rlL-12 was 
supplied by Genetics Institute (Cambridge, MA), human rlFN-c~ 
A/D was supplied by Hoffmann-La Roche (Geneva, Switzerland); 
murine rlFN-3' was supplied by Genentech, Inc. (South San Fran- 
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of Health (Bethesda, MD). IL-6 and antiphosphotyrosine RC20 
were purchased from Upstate Biotechnology  Inc. (Lake  Placid, NY). 
Anti-STAT antisera were produced as described (5) using fusion 
proteins  of glutathione  S-transferase to  the  less homologous 
COOH-terminal regions of STAT family members. 
Animals and Cell Lines.  The Thl clone 3F6 was derived  by OVA 
stimulation from DOl1.10 transgenic splenocytes  in the presence 
of anti-IL-4 followed by limiting dilution cloning (33, 34), and it 
was maintained by 3-d stimulation of 107 T cells with 3  x  10  s 
Balb/c splenocytes,  500 nM OVA, and 40 U/ml IL-2  in supplemented 
IMDM with 10% FCS, followed by a 7-d period of expansion in 
media with 11.-2 alone. For cytokine  assays  (34), 3F6 cells  were stimu- 
lated in 2-ml cultures with 2  ￿  10  s T cells and 5  x  106 spleno- 
cytes. For nuclear extracts  and immunoprecipitations,  3F6 cells  were 
harvested at approximately day 10 after stimulation and were free 
of contaminating feeder cells. The murine fibroblast line 3T3, the 
murine thymoma line EL4, and the murine hepatocyte cell line 
HepG2 were grown in DMEM with 10% FCS. Female  Balb/c  mice 
were obtained from Harlan Sprague Dawley Inc. (Indianapolis,  IN). 
Nuclear Extracts and Electrophoretic Mobility Shift Assay (EMSA). 
3F6 cells were stimulated for 30 rain with 200 U/ml IL-4, 10 U/ml 
IL-12, 1,000 U/ml IFN-%  or 300 U/ml IFN-c~, and nuclear ex- 
tracts were prepared as previously described (35). 3T3 or HepG2 
cells were stimulated for 15 rain with 100 ng/ml PDGF-BB or 30 
ng/ml II.-6 before preparation of extracts as described (31). EMSAs 
were performed as described (35). Briefly, nuclear extracts (3 #g) 
were incubated at  room  temperature with a2P-labeled m67 or 
Fc3'RI probe (1 ng, 2  x  10  s cpm) in binding buffer with 1 #g 
poly-dldC for 30 rain before addition of gel loading buffer and 
electrophoresis at room temperature on polyacrylamide  gels (4.5% 
with 2.5% glycerol  in 0.4 x TBE). Antibody supershifts were per- 
formed by adding 2 #1 of diluted antiserum (1:10 in binding buffer) 
to binding reactions for 30 min before electrophoresis. 
Immunoprecipitation and SDS-PAGE.  Total  cellular  lysates  of 2-5 
x  107 cells were immunoprecipitated as described (32) and sepa- 
rated by electrophoresis  on 7% SDS-PAGE. After transfer  to nitrocel- 
lulose, blots were probed with RC20 (1:2,500). Blots were then 
stripped and reprobed with anti-STAT antisera (1:3,000). 
Oligonucteotide Probes and Competitors.  The following double- 
stranded oligonucleotides were used in EMSA experiments: m67, 
GTCGACATTTCCCGTAAATCGTCGA;  FcyRI, TCGACGCAT- 
G'ITI'CAAGGATTTGAGATGTATTTCCCAGAAAAGGCTCGA; 
FcTRI.2, TCGACG~CCAGAAAAGGAACCTCGA; ISRE, 
GATCCTTCAGTTTCGGTTTCCCTTTCCC;  P3,1, GATCCA- 
AGCCCAAGAGTTTCCTTTTATTCGTCGA; P),2, TCGACT- 
GCTTTCAGAGAATCCCACACTCGA; P3'3, GAAGTAAAA- 
GTGCTTTCAGAGAATCCCACAAGAATGGCAC;  P'y4, GGC- 
TGTCTCATCGTCAGAGAGCCCAAGGAGTCGA;  Py5, GGC- 
CAAGGAGTCGAAAGGAAACTCTAACATGCC; P'y6, TGT- 
AACATGC  CACAAAACCATAGCTGTAATGCAAAG;  P77, 
CCCCCCACCTATCTGTCACCATCTTAACC; and PyS, GGA- 
TTACGTATTTTCACAAGTTTTTTTCC. 
Luciferase Reporter Constructs and Transient Transfections.  Various 
regions of the IFN-3' promoter  were amplified by PCR from 
genomic templates (provided by Dr. H. Fox, Department of Im- 
munology,  Scripps Clinic,  La Jolla,  CA)  and placed into  the 
SalI/BgllI  sites of the luciferase reported plasmid pBS-Luc (35). 
These sequences have  been previously  reported (35a). Promoter con- 
structs spanned the region from  -3448 to  +36,  -178 to  +36, 
or - 56 to + 36. All plasmid  constructs  were cesium chloride-banded 
twice and verified  by sequence. Electroporation, stimulation, and 
luciferase assays  were performed as described (35). Cells were stimu- 
lated 12  h  after transfection with 50  ng/ml PMA and  1 /tM 
ionomycin  and assayed  for luciferase  activity 5 h later. For cytokine 
stimulation, 1I.-12 was added at 10 U/ml 2 h after transfection. 
Data are presented as the mean of duplicate determinations of rela- 
tive light units (RLU) normalized for transfection efficiency  by 
CMV-CAT reporter plasmid (35). Each experiment was repeated 
at least three times. 
Results 
Identification of  a Celtular Model for IL-12 Signaling.  Freshly 
isolated naive CD4 + T cells are an ideal model of IL-12 re- 
sponsiveness (2), but isolation of sufficient cell numbers limits 
their use for Western blot and EMSA analysis. Immortalized 
cell lines are convenient for analysis of signaling pathways, 
but  none of the  transformed T  cell  lines  we  have  tested 
responded to IL-12 by IFN-~/production or proliferative re- 
sponses.  However, we identified several antigen-dependent 
CD4 + T cell clones responsive  to IL-12. For the Thl clone 
3F6 (34, 35), addition of IL-12 during antigen activation with 
OVA produced a threefold augmentation of IFN-3' produc- 
tion (Fig.  1). This degree of augmentation by IL-12 is typ- 
ical of many Thl cells, which, unlike naive T cells, produce 
IFN-3' even without the addition of IL-12 (2, 34, 36). Thus, 
3F6 appeared to be a useful system for examining IL-12 sig- 
naling. 
IL-12 Induces Tyrosine Phosphorflation of  Stat3 and Stat4.  Cy- 
toplasmic extracts of IL-12-treated  or untreated 3F6 cells were 
precipitated using one of four STAT-specific antisera,  sepa- 
rated by SDS-PAGE, and examined for phosphotyrosine in- 
corporation into proteins of the 90-100-kD size range (Fig. 
2). IL-12 induced tyrosine phosphorylation of  both Stat3 and 
Star4, whereas IFN-t~ caused tyrosine phosphorylation of nei- 
ther. We confirmed the presence of non-tyrosine-phosphor- 
ylated Stat3  and Stat4 in unstimulated cells by reprobing 
stripped blots with antisera to Stat3 and Stat4 (Fig.  2 A). 
3F6 secretes IFN-3, after antigen activation, resulting in the 
constitutive phosphorylation of Statl in these cells (Fig.  2 
B). 3F6 cells express low levels of Star2,  which is not acti- 
vated by IL-12  (data not shown). 
To determine whether tyrosine phosphorylation of Star3 
and Stat4 by IL-12 results in their homodimerization or het- 
erodimerization, we precipitated complexes from IL-12-treated 
3F6 cells using Stat3- and Stat4-specific antisera and probed 
Western blots with various anti-STAT  antisera  or the an- 
tiphosphotyrosine reagent RC20 (Fig. 2 B). As expected, Stat3 
and Stat4 complexes immunoprecipitated from IL-12-treated 
cells contained phosphotyrosine. The overall amount of phos- 
phorylated Stat4 appeared  significantly greater than phos- 
phorylated Stat3 or Statl. Antiphosphotyrosine RC20 rec- 
ognized bands of two distinct molecular weights in complexes 
immunoprecipitated by anti-Star3 antisera. Complexes precipi- 
tated by anti-Stat3 also contained Stat4, clearly distinguish- 
able by its higher molecular weight and reactivity with Stat4 
antiserum (Fig. 2 B). This coprecipitation of Stat4 with Stat3 
is specific to IL-12 treatment, suggesting that it results from 
cytokine activation rather than simply antibody cross-reactivity. 
In contrast, Stat3-immunoreactive material was not detect- 
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Figure  1.  IL-12  augments production of IFN-? by the OVA-reactive 
Thl clone 3F6. (A) 3F6 ceils were stimulated with splenocytes,  Ib2, and 
OVA peptide. Supernatants  were collected  after 36 h and analyzed  by ELISA 
for IFN-'y production. (B) 3F6 cells were stimulated with splenocytes, 
Ib2, 50 nM OVA, and IL-12.3F6 cells used for all experiments were har- 
vested in the quiescent phase at approximately day 10 after passage with 
OVA and Ib2 and were nonproliferative before stimulation. The sensi- 
tivity of the IFN-'y ELISA is ".,1 U/ml. 
able in complexes precipitated with anti-Stat4 antisera,  sug- 
gesting a relative abundance of phosphorylated Stat4 produc- 
tion  compared  with  phosphorylated  Stat3.  These  results 
indicate that IL-12-induced phosphorylation of Star3 and Stat4 
generates  a  heterodimer  of Stat3  and  Star4  and  a probable 
homodimer of Stat4. Without additional experiments, how- 
ever, we cannot rule out the association of either STAT with 
a  currently unidentified  component. 
IL-12 Activates Stat3 and Stat4 for DNA Binding.  To de- 
termine whether the IL-12-induced STAT factors could bind 
DNA, we used two oligonucleotide probes. The m67 probe, 
derived from the serum-inducible element of the c-J~s pro- 
moter (37), and the Fc'yRI probe, from the IFN-'y response 
region of the high affinity Fc'y receptor promoter (38), have 
distinct binding specificity for various STAT family members. 
IL-12 induced the formation of nuclear complexes with the 
FcyRI probe within  10 rain of stimulation  (Fig. 3 A) at as 
little  as  1  U/ml  IL-12  (Fig.  3  B).  The formation  of these 
IL-12-induced complexes was dependent upon tyrosine phos- 
phorylation,  since  the  protein  tyrosine  kinase  inhibitor 
genistein  blocked  their  generation  (Fig.  3  C). 
In addition, we used treatment of cells with other cytokines 
to compare the migration of IL-12-induced STATs with var- 
ious known STAT factors. Using the m67 probe, IFN-cr in- 
duced the expected Statl  homodimer (SIF-C)  (Fig. 4),  and 
Figure 3.  II.-12 induction  of 
nuclear complexes binding  the 
FcyRl  probe  requires tyrosine 
phosphorylation. 3F6 cells were 
treated (A) with 10 U/ml Ib12 
for  the  indicated number  of 
minutes, or (B) for 10 min with 
0, 0.04, 1, 5, or 25 U/ml I1.-12, 
and  nuclear extracts were pre- 
pared.  (C)  3F6  cells  were 
pretreated for 3 h with the indi- 
cated concentrations (100 or 200 
/~g/ml) of  genistein  before  10-min 
stimulation with IL-12  (10 U/ml). 
EMSA was carried out with the 
FcyRI probe. 
IL-6 induced the expected Stat3 homodimer  (SIF-A). Each 
of these was clearly distinct from the pattern of complexes 
induced by IL-12  (Fig.  4 A).  PDGF  induced  the expected 
three complexes, Stat3 homodimers (SIF-A), Statl homodimers 
(SIF-C), and Statl/Stat3 heterodimers (SIF-B, Fig. 4 A) (4). 
By comparison, IL-12 induced one lower band migrating with 
SIF-C,  but  with  a closely spaced upper doublet  with  mo- 
bility differing from SIF-A and SIF-B (Fig. 4 A, lane 3). Thus, 
with  the m67 probe,  it was difficult to distinguish  the IL- 
12-induced  complexes  from  SIF-A  and  SIF-B  induced  by 
PDGF. 
However, the Fc'yRI probe allowed clearer differentiation 
of the complexes induced by these cytokines. Using the FcyRI 
probe, IL-12 induced a broad complex of slow mobility (Fig. 
4 B), whereas IL-6-, PDGF-, and IFN-c~-induced complexes 
did not bind well to this probe. The IL-4-induced complex, 
which bound poorly to the m67 probe,  produced a strong 
Figure 2.  IL-12  treatment induces tyrosine  phosphorylation  of  Stat3 
and Stat4. Whole-cell  lysates  were prepared  from 3F6 cells treated  with 
IFN-? or IL-12  and immunoprecipitated  with anti-STAT  antisera. After 
separation by SDS-PAGE  (7% gel) and transfer to nitrocellulose,  the 
blot was probed with antiphosphotyrosine RC20 and then stripped 
and reprobed with anti-STAT  antisera. (A/IFN-c~ or Ib12-stimulated 
3F6 extracts  were precipitated  with anti-Stat3 or anti-Stat4 and probed 
with RC20, followed  by stripping and reprobing  with respective  STAT 
antisera. (B) Control or IL-12-stimulated extracts, precipitated with 
normal serum (N) or anti-Statl, 3, or 4 antisera, were probed with 
RC20 or with each STAT antisera as indicated. 
1757  Jacobson  et al. Figure 4.  II.-12  induces a unique pattern of nuclear complexes binding to (A) the m67 and (B) FcyRI oligonucleotides. Extracts were prepared 
from 3F6 cells treated with media, IFN-a,  II.-12, or 11.-4; 3T3 cells treated with PDGF; and HepG2 cells treated with IL-6. 
band with a faster mobility than the IL-12-induced complex 
with the Fc'yR.I probe. In summary,  IL-12 induced nuclear 
complexes  with  a  distinct  pattern  of mobility  and  probe 
specificity from factors composed strictly of Statl,  Stat3, or 
IL-4 Stat (Stat6). (During the preparation of this manuscript, 
a new protein termed IL-4 Star,  distinct from Statl through 
StatS,  has been described [39]; presumably, the IL-4-induced 
protein  complex we observed contains  this  new protein.) 
To further  characterize  these complexes,  we determined 
their reactivity to various anti-STAT antisera,  using both m67 
and Fc3'R.I probes. With the Fc3,RI probe, Stat4 and Stat3 
antisera removed the majority of IL-12-induced complexes 
(Fig.  5 A,  lanes  6 and  7),  whereas Statl  and Stat2 antisera 
were ineffective.  By contrast, the IL-4-induced complex was 
unaffected by any of these four antisera.  With the m67 probe, 
the IL-12-induced complexes reacted specifically with Statl, 
3,  and 4 antisera  (Fig.  5 C).  The lower band,  comigrating 
with SIF-C, was affected only by Statl antiserum (Fig.  5 C, 
lane 2). This Statl-containing  complex is not seen with the 
Fc3~RI probe because the relative affinity of that  probe for 
Statl is much lower. The upper doublet shifted completely 
with Stat4 antiserum  and nearly completely with Stat3 an- 
tiserum  (Fig.  5 C,  lanes 4 and 5).  Star2  antiserum  had no 
effect on these bands. As controls, the supershifts of PDGF- 
treated extracts yielded the expected shift pattern with Statl 
and Star3 antisera and showed no effect with Star4 antiserum 
(Fig.  5 D). 
No Evidence  for Direct Interaction of  Stat3  /Stat4 with the IFN-T 
Promoter.  IL-12's augmentation  of IFN-3' production in T 
cells and NK cells could be mediated either by direct action 
of STAT factors on the IFN-y promoter  or by an indirect 
pathway involving the modification and/or induction of sec- 
ondary intermediate proteins. To determine whether the IL- 
12-induced STAT factors identified above could be interacting 
directly with cis-acting  elements within the proximal IFN-y 
promoter region, we have initiated studies on this promoter 
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but not to IL-12  stimulation. EL4 cells were transiently  transfected  with 
routine reporter  constructs spanning from -3447,  -178, to -56 bp in 
the IFN-3,  promoter  and stimulated  with PMA and ionomycin  (5 h) and/or 
IL-12 (15 h). Luciferase  assay measurements are reported in RLU. 
Figure  5.  IL-12-induced  nuclear  complexes  contain  Stat3 and Stat4. Nu- 
clear extracts  of 3F6 cells were prepared  after (A) IL12 treatment, or (B) 
IL-4 treatment. EMSA was performed  with the Fc3'R.I probe  and antisera 
to Statl, 2, 3, and 4. (C) IL-12-treated  3F6 nuclear  extracts, or (D) PDGF- 
treated 3T3 cell extracts were supershifted using the m67 probe. 
region.  Previously,  others  have  found  that  an  immediate 
5' flanking region from -  108 to  - 40 bp mediates inducible 
reporter activity in human T  cells (40). We have produced 
a series of  luciferase-based mouse reporter constructs to confirm 
these findings in the mouse system and to examine the re- 
sponses  of this region to IL-12 (see Fig. 7). As reported for 
the human promoter (40), we find that PMA and ionomycin 
responsiveness lie within the  -  178 to  - 56 bp region of the 
proximal promoter. However, this region of IFN-3, promoter 
does not appear to confer IL-12 responsiveness  to the reporter 
when expressed either in the murine thymoma EL4 (Fig.  6), 
in the transfectable IL-12 responsive OI17, or in the human 
T cell line Kit225 (data not shown). Furthermore, we exam- 
ined the IFN-y promoter (Fig.  7 A) for direct interaction 
with IL-12-induced STAT factors in EMSA using the m67 
probe and IL-12-stimulated 3F6 nuclear extracts (Fig.  7 B). 
For this analysis we examined oligonucleotides  spanning several 
hundred base pairs of the proximal promoter important for 
inducible activity. None of the competitors from the IFN-'y 
promoter inhibited IL-12-induced STAT factor binding to 
the m67 probe (Fig.  7 B).  As controls for inhibition,  we 
showed that m67 and Fc3~tkI competitors blocked complex 
formation (Fig.  7 B).  These results suggest the possibility 
that the effect of IL-12 on the IFN-'y promoter may be in- 
direct or mediated by sites outside the immediate 5' promoter. 
Discussion 
IL-12 induces Thl development (1,  2)  and is critical to 
pathogen resistance by promoting cell-mediated immunity 
via both T  cells and NK cells (13-15). One subunit of IL- 
12R has been cloned and is homologous to gp130, with box 
I and box 2 motifs (41, 42). Additional receptor components 
are likely to be necessary for high affinity binding, however 
(42).  Bacon et al.  recently found that  IL-12 activates Jak2 
and Tyk2 tyrosine kinases  in activated human T  cells (43). 
IL-12 may also induce tyrosine phosphorylation of putative 
mitogen-activated protein kinases  (44), but, in our Western 
blots  of 3F6  lysates,  IL-12-induced phosphotyrosine was 
present only in proteins of ,x,90 kD (data not shown). Taken 
together, current data support the hypothesis that IL-12 uses 
specific members of the Jak-STAT pathway for signal trans- 
duction. 
Stat4 was recently cloned in two laboratories by its ho- 
mology to Statl  (5,  6) but was not found to be activated 
by any natural ligand in numerous cell types. While Statl 
is widely expressed, Stat4 expression was restricted to the 
testis and a few other tissues  including the spleen.  Stat4 is 
Figure  7.  IL-12-induced  nuclear  factors  do not bind to oligonucleotide 
competitors from the  IFN-y promoter. (A)  Oligonucleotide probes 
P3'I-P'y8 span the proximal  '~400  bp of  IFN-3' promoter  and include  puta- 
tive GATA-3,  NFIL2A-like,  and GMCSF-like  sites described  by Penix  et 
ah (41). (B) Nuclear  extracts  from IL-12-induced  3F6 cells  were  incubated 
with radiolabeled  m67 probe  in the presence  or absence  of 20 ng compet- 
itor DNA as indicated and resolved by EMSA. 
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isolated CD4 § T cells, other CD4 + T cell clones, the CD8 + 
T cell clone L3, and the NK cell line CRNK5 contain Stat4 
and generate Stat4-containing,  IL-12-induced complexes (data 
not shown). 
Like many other Thl clones, 3F6 responds to IL-12 stim- 
ulation with only a severalfold increase in IFN-'y production. 
While naive T ceils exhibit a more dramatic developmental 
response to IL-12 by greatly increasing subsequent IFN-'y 
production, naive CD4 § cells are unable to produce signifi- 
cant amounts of IFN-y without IL-12 treatment (2). Because 
Thl clones retain responsiveness  to IL-12 for augmentation 
of IFN-'y production and can be conveniently manipulated 
in vitro, they provided a suitable model for our initial charac- 
terization of IL-12  signaling. 
Based on the reactivity with anti-STAT  antisera (Fig.  5) 
and results from coimmunoprecipitations (Fig. 2 B), it is likely 
that IL-12 induces at least two types of STAT-containing com- 
plexes (4). Our data support the presence of some Stat3/Stat4 
heterodimers and imply that the Stat4 homodimers (or acti- 
vated Stat4 in association with a currently unknown compo- 
nent) comprise most of the IL-12-induced complexes. 
Among the well-characterized effects of IL-12 is the rapid 
induction of IFN-q' transcription (26, 27), although the mech- 
anism of this action is currently unknown. In our analysis 
of the proximal IFN-3, promoter,  a region important for 
transcription in T  cells (40),  we found no direct evidence 
of interaction between the IL-12-induced STAT factors and 
cis-acting elements. While we cannot rule out direct interac- 
tions of Stat3/Stat4 with cis-acting elements in other regions 
of the IFN-3, gene, these results may suggest an indirect mode 
of action of IL-12 on IFN-y. This situation would be similar 
to the indirect action of IFN-3, for augmenting target genes, 
such as inducible nitric oxide synthase, through the inter- 
mediate induction of IRF-1  (45). 
IL-12 is currently under evaluation as an immunotherapeutic 
and antitumor adjuvant, and it represents  an important link 
between innate immunity and specific immune responses (46, 
47). This study provides the first characterization of the IL- 
12 signal  transduction pathway and the first  identification 
of a physiologic activator of Stat4.  These observations may 
provide a basis for understanding the development of cell- 
mediated immunity. 
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